Lakefront Biotherapeutics (LKFT) Goodwill (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Goodwill for 13 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.

• Quarterly Goodwill fell 96.08% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (down 96.08% YoY) and the FY2025 annual result came in at $3.4 million, down 95.72% from the prior year.
• Goodwill slipped to $3.1 million in Q1 2026 per LKFT's latest filing, from $3.4 million in the prior quarter.
• Over the last five years, Goodwill for LKFT reached as high as $79.7 million in Q4 2024 and fell as low as -$1.9 million in Q1 2022.
• A 5-year average of $55.5 million and a median of $79.2 million in 2023 frame the typical range for Goodwill.
• Annual changes were most pronounced in 2023 — Goodwill surged 4227.49% — and 2026, when it tumbled 96.08%.
• Year by year, Goodwill stood at $79.4 million in 2022, then retreated by 0.37% to $79.2 million in 2023, then advanced by 0.65% to $79.7 million in 2024, then sank by 95.72% to $3.4 million in 2025, then fell by 8.74% to $3.1 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $3.1 million, $3.4 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.